There were 60 patients (2.7%) in the SGLT2 cohort and 180 patients (4.1%) in the DPP4 cohort who experienced a heart failure hospitalization event (aHR = 0.72, 95% CI 0.54–0.97; p = 0.030). Here, SLC5A2 is linked to heart failure.